It is becoming clear that multiple forms of cognitive ability or susceptibility to neurodegenerative disorders are affected by general systemic metabolic function. Thus, cognitive health is tightly linked to metabolic health. Previously, we have already pioneered this work by linking the progression of Huntingtons disease to a diabetic-like state. It is clear from several lines of evidence, including our own, that hormones responsible for metabolic regulation also play vital roles in cognitive function. For example, we have previously shown that Exendin-4, which is a long-acting analogue of the gut hormone Glucagon-like peptide 1 (GLP-1) can improve euglycemia, protect pancreatic islet function, improve motor coordination and reduce mutant huntingin aggregates in a mouse model of Huntingtons disease. It is likely that through the creation of multiple types of metabolically-targeted therapeutics, there will also be the creation of distinct mechanisms by which these strategies affect cognitive function. Currently we are investigating underlying metabolic dysunction in various neurological disorders, such as Alzheimer's disease, Huntington's disease, Autism Spectrum disorder, Post-partum depression, and WAGR syndrom. Our goal is to first understand how multiple types of glycemic and metabolic control can affect neuronal function and then to tailor distinct novel therapeutics which can maintain or enhance both metabolic and cognitive function.

National Institute of Health (NIH)
National Institute on Aging (NIA)
Investigator-Initiated Intramural Research Projects (ZIA)
Project #
Application #
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
National Institute on Aging
Zip Code
Wu, Wells W; Shen, Rong-Fong; Park, Sung-Soo et al. (2012) Precursor ion exclusion for enhanced identification of plasma biomarkers. Proteomics Clin Appl 6:304-8
Chadwick, Wayne; Martin, Bronwen; Chapter, Megan C et al. (2012) GIT2 acts as a potential keystone protein in functional hypothalamic networks associated with age-related phenotypic changes in rats. PLoS One 7:e36975
Stranahan, Alexis M; Martin, Bronwen; Maudsley, Stuart (2012) Anti-inflammatory effects of physical activity in relationship to improved cognitive status in humans and mouse models of Alzheimer's disease. Curr Alzheimer Res 9:86-92
Hallböök, Tove; Ji, Sunggoan; Maudsley, Stuart et al. (2012) The effects of the ketogenic diet on behavior and cognition. Epilepsy Res 100:304-9
Shin, Yu-Kyong; Cong, Wei-na; Cai, Huan et al. (2012) Age-related changes in mouse taste bud morphology, hormone expression, and taste responsivity. J Gerontol A Biol Sci Med Sci 67:336-44
Jiang, Mali; Wang, Jiawei; Fu, Jinrong et al. (2012) Neuroprotective role of Sirt1 in mammalian models of Huntington's disease through activation of multiple Sirt1 targets. Nat Med 18:153-8
Jasien, Joan; Daimon, Caitlin M; Maudsley, Stuart et al. (2012) Aging and bone health in individuals with developmental disabilities. Int J Endocrinol 2012:469235
Schwartz, Catherine M; Tavakoli, Tahereh; Jamias, Charmaine et al. (2012) Stromal factors SDF1*, sFRP1, and VEGFD induce dopaminergic neuron differentiation of human pluripotent stem cells. J Neurosci Res 90:1367-81
Cai, Huan; Cong, Wei-na; Ji, Sunggoan et al. (2012) Metabolic dysfunction in Alzheimer's disease and related neurodegenerative disorders. Curr Alzheimer Res 9:5-17
Martin, Bronwen; Chadwick, Wayne; Yi, Tie et al. (2012) VENNTURE--a novel Venn diagram investigational tool for multiple pharmacological dataset analysis. PLoS One 7:e36911

Showing the most recent 10 out of 47 publications